Finally, in silico analysis of VEGFR3/FLT4/CD310 expression in samples from cancer patients revealed higher expression of VEGFR3/FLT4/CD310 in metastatic tumors, as well as an association between VEGFR3/FLT4/CD310 expression and poorer patient survival. The gene discussed is FLT4; the disease is cancer.